ABCD now on N3: The ABCD nationwide exenatide QW audit
DOI:
https://doi.org/10.15277/bjdvd.2014.009References
Walton C. Entering a new era. Br J Diabetes Vasc Dis 2014;14(1):1.
The history of the ABCD nationwide audit programme. Available at http://www.diabetologists-abcd.org.uk/n3/previous_ABCD_ audits.htm (2014, accessed 3 March 2014)
Ryder B, Thong K, the ABCD nationwide exenatide and nationwide liraglutide audit contributors. Findings from the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits. In Hot topics in diabetes, Vora J, ed. Synergy, London, 2012. Available at http://www.diabetologists-abcd.org.uk/GLP1_Audits/ABCD_Hot_Topics_2012.pdf (2012, accessed 3 March 2014)
Thong KY, Jose B, Sukumar N et al. Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit. Diab Obes Metab 2011;13: 703-10. http://dx.doi.org/10.1111/j.1463-1326.2011.01393.x
Thong KY, Jose B, Blann AD et al. Response at 3 months to insulin dose decisions made at exenatide initiation in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit. Diab Res Clin Pract 2011;93:e87-91. http://dx.doi.org/10.1016/j.diabres.2011.05.015
Thong KY, Cull ML, Ryder REJ et al. Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon-like peptide 1 (GLP-1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits. Diabet Med 2012; 29(5):690-92. http://dx.doi.org/10.1111/j.1464-5491.2011.03475.x
Thong KY, Walton C, Ryder REJ, the ABCD nationwide liraglutide audit contributors. Safety and efficacy of liraglutide 1.2mg in patients with mild and moderate renal impairment:the ABCD nationwide liraglutide audit. Practical Diabetes 2013;30(2):71-6. http://dx.doi.org/10.1002/pdi.1748
Ryder REJ, Thong KY, Blann AD et al. Liraglutide pancreatitis: The ABCD nationwide liraglutide audit. Br J Diabetes Vasc Dis 2013;13:253-9. http://dx.doi.org/10.1177/1474651413502685
Ryder REJ, Sen Gupta P, Thong KY et al. The Association of British Clinical Diabetologists nationwide exenatide and liraglutide audits suggest a low incidence of acute pancreatitis. Response to Robson. Incretins and pancreatitis—what happens next? A personal viewpoint. Diabet Med 2013;30(12):1510-11. http://dx.doi.org/10.1111/dme.12336
ABCD nationwide exenatide QW audit on N3. Available at http://www.diabetologists-abcd.org.uk/n3/ExenatideQW_Audit.htm (2014, accessed 3 March 2014)
Published
Issue
Section
License
Publish & Transfer of Copyright Agreement
For the mutual benefit and protection of the Author and the Journal Owner/Publisher it is necessary that the Author provides formal written Consent to Publish and Transfer of Copyright before publication of the Work.
